Engineered virus targets HIV-infected cells: interview with Garry Nolan, Ph.D. Interview by John S. James

Real-world use of long-acting cabotegravir and rilpivirine: 12-month results of the inJectable Antiretroviral therapy feasiBility Study (JABS).

HIV medicine·2024

Practice Guidelines for Standards of Adult Sleep Medicine Services.

Irish medical journal·2018

Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation.

Mucosal immunology·2017

An anatomical study of the intersigmoid fossa and applications for internal hernia surgery.

Surgical and radiologic anatomy : SRA·2016

Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells.

Leukemia·2016

Disordered breathing during sleep and exercise in idiopathic pulmonary fibrosis and the role of biomarkers.

QJM : monthly journal of the Association of Physicians·2014

New kind of antiretroviral, KP-1461; clinical trial recruiting. Interview with Stephen Becker, M.D.

AIDS treatment news·2008

Flu shot reminder.

AIDS treatment news·2008

AIDS search engine wanted: what to do now?

AIDS treatment news·2007

Is cure possible for HIV?

AIDS treatment news·2007

Financial accounts that can reproduce, inherit, and evolve.

AIDS treatment news·2007

Selling digital art in bulk through prepaid URLs.

AIDS treatment news·2007

Novel Use of Mavacamten in RAF1-Associated Noonan Syndrome With Hypertrophic Cardiomyopathy.

JACC. Case reports·2026

Emergence of neutralizing RBD antibodies following Omicron infection with limited activity against ancestral SARS-CoV-2.

iScience·2026

Functional and Anatomic Outcomes at 12 Months After Switching to Faricimab in Treatment-Recalcitrant Neovascular Age-Related Macular Degeneration.

Journal of vitreoretinal diseases·2026

Moving from Bench to Bedside: A Social History of Actionability in Biomedicine.

medRxiv : the preprint server for health sciences·2026

Characterization of Immune Responses to RBD-SD1 Nanoparticle Vaccines Derived From ACE2-Capable HKU5-CoV-2, NeoCoV, and HKU5 Merbecoviruses.

Biotechnology and bioengineering·2026

Myricetin-functionalized Prussian blue nanoparticles enable multi-modal therapy against methicillin-resistant Staphylococcus aureus and accelerate wound repair.

Acta biochimica et biophysica Sinica·2026

Related Experiment Videos

Engineered virus targets HIV-infected cells: interview with Garry Nolan, Ph.D. Interview by John S. James

Related Concept Videos

Real-world use of long-acting cabotegravir and rilpivirine: 12-month results of the inJectable Antiretroviral therapy feasiBility Study (JABS).

Practice Guidelines for Standards of Adult Sleep Medicine Services.

Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation.

An anatomical study of the intersigmoid fossa and applications for internal hernia surgery.

Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells.

Disordered breathing during sleep and exercise in idiopathic pulmonary fibrosis and the role of biomarkers.

New kind of antiretroviral, KP-1461; clinical trial recruiting. Interview with Stephen Becker, M.D.

Flu shot reminder.

AIDS search engine wanted: what to do now?

Is cure possible for HIV?

Financial accounts that can reproduce, inherit, and evolve.

Selling digital art in bulk through prepaid URLs.

Novel Use of Mavacamten in RAF1-Associated Noonan Syndrome With Hypertrophic Cardiomyopathy.

Emergence of neutralizing RBD antibodies following Omicron infection with limited activity against ancestral SARS-CoV-2.

Functional and Anatomic Outcomes at 12 Months After Switching to Faricimab in Treatment-Recalcitrant Neovascular Age-Related Macular Degeneration.

Moving from Bench to Bedside: A Social History of Actionability in Biomedicine.

Characterization of Immune Responses to RBD-SD1 Nanoparticle Vaccines Derived From ACE2-Capable HKU5-CoV-2, NeoCoV, and HKU5 Merbecoviruses.

Myricetin-functionalized Prussian blue nanoparticles enable multi-modal therapy against methicillin-resistant Staphylococcus aureus and accelerate wound repair.

Related Experiment Videos

Engineered virus targets HIV-infected cells: interview with Garry Nolan, Ph.D. Interview by John S. James

Related Concept Videos

Related Articles